ID   CP4B1_HUMAN             Reviewed;         511 AA.
AC   P13584; Q1HBI2; Q8TD85; Q8WWF2; Q8WWU9; Q8WWV0;
DT   01-JAN-1990, integrated into UniProtKB/Swiss-Prot.
DT   07-JUN-2004, sequence version 2.
DT   10-MAY-2017, entry version 165.
DE   RecName: Full=Cytochrome P450 4B1;
DE            EC=1.14.14.1;
DE   AltName: Full=CYPIVB1;
DE   AltName: Full=Cytochrome P450-HP;
GN   Name=CYP4B1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=2574990; DOI=10.1021/bi00446a014;
RA   Nhamburo P.T., Gonzalez F.J., McBride O.W., Gelboin H.V., Kimura S.;
RT   "Identification of a new P450 expressed in human lung: complete cDNA
RT   sequence, cDNA-directed expression, and chromosome mapping.";
RL   Biochemistry 28:8060-8066(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=2298205; DOI=10.1111/j.1432-1033.1990.tb15273.x;
RA   Yokotani N., Sogawa K., Matsubara S., Gotoh O., Kusunose E.,
RA   Kusunose M., Fujii-Kuriyama Y.;
RT   "cDNA cloning of cytochrome P-450 related to P-450p-2 from the cDNA
RT   library of human placenta. Gene structure and expression.";
RL   Eur. J. Biochem. 187:23-29(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS TRP-173; GLY-322;
RP   ILE-331; CYS-340 AND CYS-375.
RX   PubMed=12142726; DOI=10.1097/00008571-200207000-00004;
RA   Lo-Guidice J.-M., Allorge D., Cauffiez C., Chevalier D.,
RA   Lafitte J.-J., Lhermitte M., Broly F.;
RT   "Genetic polymorphism of the human cytochrome P450 CYP4B1: evidence
RT   for a non-functional allelic variant.";
RL   Pharmacogenetics 12:367-374(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND TISSUE SPECIFICITY.
RC   TISSUE=Lung;
RX   PubMed=12695542; DOI=10.1124/mol.63.5.1137;
RA   Carr B.A., Ramakanth S., Dannan G.A., Yost G.S.;
RT   "Characterization of pulmonary CYP4B2, specific catalyst of methyl
RT   oxidation of 3-methylindole.";
RL   Mol. Pharmacol. 63:1137-1147(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS VAL-111; TRP-173;
RP   TRP-264; GLN-274; GLY-322; SER-329; ILE-331; CYS-340; CYS-354; CYS-375
RP   AND GLN-482.
RG   NIEHS SNPs program;
RL   Submitted (APR-2006) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Cytochromes P450 are a group of heme-thiolate
CC       monooxygenases. In liver microsomes, this enzyme is involved in an
CC       NADPH-dependent electron transport pathway. It oxidizes a variety
CC       of structurally unrelated compounds, including steroids, fatty
CC       acids, and xenobiotics.
CC   -!- CATALYTIC ACTIVITY: RH + [reduced NADPH--hemoprotein reductase] +
CC       O(2) = ROH + [oxidized NADPH--hemoprotein reductase] + H(2)O.
CC   -!- COFACTOR:
CC       Name=heme; Xref=ChEBI:CHEBI:30413;
CC         Evidence={ECO:0000250|UniProtKB:P51869};
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Peripheral
CC       membrane protein. Microsome membrane; Peripheral membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P13584-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P13584-2; Sequence=VSP_038419;
CC   -!- TISSUE SPECIFICITY: Detected in the liver and lung (at protein
CC       level). {ECO:0000269|PubMed:12695542}.
CC   -!- INDUCTION: P450 can be induced to high levels in liver and other
CC       tissues by various foreign compounds, including drugs, pesticides,
CC       and carcinogens.
CC   -!- SIMILARITY: Belongs to the cytochrome P450 family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Cytochrome P450 Allele Nomenclature Committee;
CC       Note=CYP4B1 alleles;
CC       URL="http://www.cypalleles.ki.se/cyp4b1.htm";
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/cyp4b1/";
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/CYP4B1ID40253ch1p33.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; J02871; AAA35712.1; -; mRNA.
DR   EMBL; X16699; CAA34672.1; -; mRNA.
DR   EMBL; AF491285; AAM09532.1; -; mRNA.
DR   EMBL; AY064485; AAL57720.1; -; mRNA.
DR   EMBL; AY064486; AAL57721.1; -; mRNA.
DR   EMBL; AY151048; AAN72311.1; -; mRNA.
DR   EMBL; DQ518907; ABF47106.1; -; Genomic_DNA.
DR   EMBL; AL593856; CAI16981.1; -; Genomic_DNA.
DR   EMBL; AL356793; CAI16981.1; JOINED; Genomic_DNA.
DR   EMBL; AL593856; CAI16982.1; -; Genomic_DNA.
DR   EMBL; AL356793; CAI16982.1; JOINED; Genomic_DNA.
DR   EMBL; AL356793; CAI22557.1; -; Genomic_DNA.
DR   EMBL; AL593856; CAI22557.1; JOINED; Genomic_DNA.
DR   EMBL; AL356793; CAI22559.1; -; Genomic_DNA.
DR   EMBL; AL593856; CAI22559.1; JOINED; Genomic_DNA.
DR   EMBL; BC017758; AAH17758.1; -; mRNA.
DR   CCDS; CCDS41328.1; -. [P13584-2]
DR   CCDS; CCDS542.1; -. [P13584-1]
DR   PIR; S07765; O4HUB1.
DR   RefSeq; NP_000770.2; NM_000779.3. [P13584-1]
DR   RefSeq; NP_001093242.1; NM_001099772.1. [P13584-2]
DR   UniGene; Hs.436317; -.
DR   ProteinModelPortal; P13584; -.
DR   SMR; P13584; -.
DR   BioGrid; 107952; 1.
DR   STRING; 9606.ENSP00000360991; -.
DR   DrugBank; DB00683; Midazolam.
DR   DrugBank; DB01174; Phenobarbital.
DR   DrugBank; DB00152; Thiamine.
DR   iPTMnet; P13584; -.
DR   PhosphoSitePlus; P13584; -.
DR   BioMuta; CYP4B1; -.
DR   DMDM; 48429213; -.
DR   PaxDb; P13584; -.
DR   PeptideAtlas; P13584; -.
DR   PRIDE; P13584; -.
DR   DNASU; 1580; -.
DR   Ensembl; ENST00000271153; ENSP00000271153; ENSG00000142973. [P13584-1]
DR   Ensembl; ENST00000371923; ENSP00000360991; ENSG00000142973. [P13584-2]
DR   GeneID; 1580; -.
DR   KEGG; hsa:1580; -.
DR   UCSC; uc001cqm.5; human. [P13584-1]
DR   CTD; 1580; -.
DR   DisGeNET; 1580; -.
DR   GeneCards; CYP4B1; -.
DR   HGNC; HGNC:2644; CYP4B1.
DR   HPA; HPA004331; -.
DR   MIM; 124075; gene.
DR   neXtProt; NX_P13584; -.
DR   OpenTargets; ENSG00000142973; -.
DR   PharmGKB; PA27119; -.
DR   eggNOG; KOG0157; Eukaryota.
DR   eggNOG; COG2124; LUCA.
DR   GeneTree; ENSGT00760000118816; -.
DR   HOGENOM; HOG000233833; -.
DR   HOVERGEN; HBG000182; -.
DR   InParanoid; P13584; -.
DR   KO; K07426; -.
DR   OMA; YPEHQSR; -.
DR   OrthoDB; EOG091G06KN; -.
DR   PhylomeDB; P13584; -.
DR   TreeFam; TF105088; -.
DR   Reactome; R-HSA-211935; Fatty acids.
DR   Reactome; R-HSA-211958; Miscellaneous substrates.
DR   Reactome; R-HSA-211979; Eicosanoids.
DR   Reactome; R-HSA-2142691; Synthesis of Leukotrienes (LT) and Eoxins (EX).
DR   ChiTaRS; CYP4B1; human.
DR   GeneWiki; CYP4B1; -.
DR   GenomeRNAi; 1580; -.
DR   PRO; PR:P13584; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000142973; -.
DR   CleanEx; HS_CYP4B1; -.
DR   ExpressionAtlas; P13584; baseline and differential.
DR   Genevisible; P13584; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0031090; C:organelle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0070330; F:aromatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0008144; F:drug binding; IEA:Ensembl.
DR   GO; GO:0018585; F:fluorene oxygenase activity; IEA:Ensembl.
DR   GO; GO:0020037; F:heme binding; IEA:InterPro.
DR   GO; GO:0005506; F:iron ion binding; IEA:InterPro.
DR   GO; GO:0019825; F:oxygen binding; TAS:Reactome.
DR   GO; GO:0015643; F:toxic substance binding; IEA:Ensembl.
DR   GO; GO:0018879; P:biphenyl metabolic process; IEA:Ensembl.
DR   GO; GO:0042738; P:exogenous drug catabolic process; IEA:Ensembl.
DR   GO; GO:0018917; P:fluorene metabolic process; IEA:Ensembl.
DR   InterPro; IPR001128; Cyt_P450.
DR   InterPro; IPR017972; Cyt_P450_CS.
DR   InterPro; IPR002401; Cyt_P450_E_grp-I.
DR   Pfam; PF00067; p450; 1.
DR   PRINTS; PR00463; EP450I.
DR   PRINTS; PR00385; P450.
DR   SUPFAM; SSF48264; SSF48264; 1.
DR   PROSITE; PS00086; CYTOCHROME_P450; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Endoplasmic reticulum; Heme;
KW   Iron; Membrane; Metal-binding; Microsome; Monooxygenase;
KW   Oxidoreductase; Polymorphism; Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000250|UniProtKB:P15129}.
FT   CHAIN         2    511       Cytochrome P450 4B1.
FT                                /FTId=PRO_0000051819.
FT   METAL       453    453       Iron (heme axial ligand).
FT                                {ECO:0000250|UniProtKB:P51869}.
FT   BINDING     315    315       Heme (covalent; via 1 link).
FT                                {ECO:0000250|UniProtKB:P51869}.
FT   VAR_SEQ     206    206       H -> HS (in isoform 2).
FT                                {ECO:0000303|PubMed:12695542,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_038419.
FT   VARIANT     111    111       A -> V (in dbSNP:rs45559437).
FT                                {ECO:0000269|Ref.5}.
FT                                /FTId=VAR_055377.
FT   VARIANT     173    173       R -> W (in allele CYP4B1*3 and allele
FT                                CYP4B1*6; dbSNP:rs4646487).
FT                                {ECO:0000269|PubMed:12142726,
FT                                ECO:0000269|Ref.5}.
FT                                /FTId=VAR_018357.
FT   VARIANT     264    264       R -> W (in dbSNP:rs45446505).
FT                                {ECO:0000269|Ref.5}.
FT                                /FTId=VAR_048453.
FT   VARIANT     274    274       R -> Q (in dbSNP:rs45578838).
FT                                {ECO:0000269|Ref.5}.
FT                                /FTId=VAR_055378.
FT   VARIANT     322    322       S -> G (in allele CYP4B1*4;
FT                                dbSNP:rs45467195).
FT                                {ECO:0000269|PubMed:12142726,
FT                                ECO:0000269|Ref.5}.
FT                                /FTId=VAR_018358.
FT   VARIANT     329    329       Y -> S (in dbSNP:rs12094024).
FT                                {ECO:0000269|Ref.5}.
FT                                /FTId=VAR_048454.
FT   VARIANT     331    331       M -> I (in allele CYP4B1*2, allele
FT                                CYP4B1*7 and allele CYP4B1*5;
FT                                dbSNP:rs2297810).
FT                                {ECO:0000269|PubMed:12142726,
FT                                ECO:0000269|Ref.5}.
FT                                /FTId=VAR_018359.
FT   VARIANT     340    340       R -> C (in allele CYP4B1*2 and allele
FT                                CYP4B1*7; dbSNP:rs4646491).
FT                                {ECO:0000269|PubMed:12142726,
FT                                ECO:0000269|Ref.5}.
FT                                /FTId=VAR_018360.
FT   VARIANT     345    345       V -> I (in allele CYP4B1*6).
FT                                /FTId=VAR_018361.
FT   VARIANT     354    354       F -> C (in dbSNP:rs17102592).
FT                                {ECO:0000269|Ref.5}.
FT                                /FTId=VAR_048455.
FT   VARIANT     375    375       R -> C (in allele CYP4B1*2;
FT                                dbSNP:rs2297809).
FT                                {ECO:0000269|PubMed:12142726,
FT                                ECO:0000269|Ref.5}.
FT                                /FTId=VAR_018362.
FT   VARIANT     482    482       R -> Q (in dbSNP:rs45622937).
FT                                {ECO:0000269|Ref.5}.
FT                                /FTId=VAR_048456.
FT   CONFLICT     37     37       Q -> R (in Ref. 1; AAA35712).
FT                                {ECO:0000305}.
SQ   SEQUENCE   511 AA;  58991 MW;  91FED40949507EB8 CRC64;
     MVPSFLSLSF SSLGLWASGL ILVLGFLKLI HLLLRRQTLA KAMDKFPGPP THWLFGHALE
     IQETGSLDKV VSWAHQFPYA HPLWFGQFIG FLNIYEPDYA KAVYSRGDPK APDVYDFFLQ
     WIGRGLLVLE GPKWLQHRKL LTPGFHYDVL KPYVAVFTES TRIMLDKWEE KAREGKSFDI
     FCDVGHMALN TLMKCTFGRG DTGLGHRDSS YYLAVSDLTL LMQQRLVSFQ YHNDFIYWLT
     PHGRRFLRAC QVAHDHTDQV IRERKAALQD EKVRKKIQNR RHLDFLDILL GARDEDDIKL
     SDADLRAEVD TFMFEGHDTT TSGISWFLYC MALYPEHQHR CREEVREILG DQDFFQWDDL
     GKMTYLTMCI KESFRLYPPV PQVYRQLSKP VTFVDGRSLP AGSLISMHIY ALHRNSAVWP
     DPEVFDSLRF STENASKRHP FAFMPFSAGP RNCIGQQFAM SEMKVVTAMC LLRFEFSLDP
     SRLPIKMPQL VLRSKNGFHL HLKPLGPGSG K
//
